Gline Matthew 4

What Happened

• Matthew Gline, CEO and director of Roivant Sciences Ltd. (ROIV), disposed of 76,171 shares on June 30, 2026 at $35.39 per share for a total of approximately $2,695,692. The transaction is a "net settlement" disposal to satisfy tax withholding obligations related to vested restricted stock units (RSUs), not an open-market sale.

Key Details

• Transaction date and price: 2026-06-30 at $35.39 per share.
• Shares disposed: 76,171; proceeds ≈ $2,695,692.
• Nature of transaction: Tax withholding via net settlement of vested RSUs (see footnote F1).
• Filing date: 2026-07-02 (report lists period 2026-06-30); filing appears to be timely per the Form 4.
• Shares owned after the transaction: not specified in the summary filing provided.

Context

• Net settlement means the company retained/surrendered a portion of the vested RSU shares to cover tax withholding rather than selling them in the open market — a common, administrative action that typically reflects tax obligations rather than a judgment about the stock. This is routine for equity compensation and should not be interpreted as a directional signal by itself.